Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Conjupro Biotherapeutics, Inc.
Atavistik Bio, Inc
NiKang Therapeutics, Inc.
Kivu Bioscience Inc.
Alterome Therapeutics, Inc.
AstraZeneca
BeOne Medicines
ViroMissile, Inc.
Arcus Biosciences, Inc.
Accent Therapeutics
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Normunity AccelCo, Inc.
Eli Lilly and Company
NiKang Therapeutics, Inc.
Poseida Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
Avacta Life Sciences Ltd
SystImmune Inc.
SN BioScience
Eli Lilly and Company
Eli Lilly and Company
Shanghai Best-Link Bioscience, LLC
Seagen Inc.
Fusion Pharmaceuticals Inc.
Innate Pharma
Novartis
National Institutes of Health Clinical Center (CC)
MOMA Therapeutics
Risen (Suzhou) Pharma Tech Co., Ltd.
Fate Therapeutics
NextCure, Inc.
NeoTX Therapeutics Ltd.
Bolt Biotherapeutics, Inc.
SystImmune Inc.
Mersana Therapeutics
Actym Therapeutics, Inc.
M.D. Anderson Cancer Center
NiKang Therapeutics, Inc.
EtiraRx Australia Pty Ltd
Exelixis
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
GONGCHU Biotechnology Co., Ltd
Exelixis
Senhwa Biosciences, Inc.
Jonsson Comprehensive Cancer Center